Month: April 2025

MONTREAL, April 24, 2025 (GLOBE NEWSWIRE) — Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) announces that the release of the 2025 first quarter results will take place on Wednesday, May 14, 2025, at 9 a.m. (previously announced at 9:30 a.m.). Financial analysts and investors are invited to attend a conference call during which the financial results will be presented. Date and time Wednesday, May 14, 2025, at 9 a.m. ET To attend the conference Webcast link: https://edge.media-server.com/mmc/p/3nwdfvm2  To attend the event by phone: Click here to register for the earnings call. Once you have completed your registration, you will receive a confirmation email containing the link and your personal PIN to connect to the call. If you lose this link and your PIN, you will be able to register again. You must register if you wish to...

Open and holistic approach to data is amplified by AI, more deeply connecting proprietary assets across Nexxen’s unified platform  The first of many advancements, a natively-integrated DSP assistant, prioritizes transparency and user control  NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) — Nexxen (NASDAQ: NEXN), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced the launch of nexAI, a comprehensive suite of artificial intelligence (“AI”)-powered assistants and features, vertically integrated across the core pillars of its end-to-end platform. Fundamentally elevating every stage of the advertising life cycle, nexAI takes a transparent approach to planning and activation as well as optimization and monetization, continuously iterating and improving to deliver greater efficiency....

HOUSTON, TX, April 24, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that its proprietary Gen-2 neurostimulation device has received institutional review board (IRB) approval in Brazil for a new clinical trial evaluating its use in the treatment of anxiety disorders and chronic insomnia. The study will be conducted at the Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (IPq-HCFMUSP), one of Latin America’s most prestigious psychiatric research institutions. The first Nexalin device has been shipped to São Paulo, Brazil, with additional units and single-use disposable electrodes scheduled for delivery in the coming days. These...

CLEARWATER, Fla., April 24, 2025 (GLOBE NEWSWIRE) — Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the first quarter of fiscal year 2025 will be released before markets open on Thursday, May 8th. Management will host a conference call at 8:00 a.m. Eastern Time on Thursday, May 8th to discuss the results of the quarter, and to host a question-and-answer session. To listen to the call by phone, interested parties may dial 800-717-1738 (or 646-307-1865 for international callers) and provide access code 63341. Participants should ask for the “Apyx Medical Corporation Call”. A live webcast of the call will be accessible via the following link: Apyx Medical...

The general meeting of shareholders of Northern Horizon Capital AS, the management company of Baltic Horizon Fund, has approved the management company’s audited annual report of year 2024. The report, together with the independent auditors’ report is available on the Baltic Horizon Fund webpage. For additional information, please contact: Tarmo Karotam Baltic Horizon Fund manager E-mail tarmo.karotam@nh-cap.com www.baltichorizon.com The Fund is a registered contractual public closed-end real estate fund that is managed by Alternative Investment Fund Manager license holder Northern Horizon Capital AS.  Distribution: GlobeNewswire, Nasdaq Tallinn, Nasdaq Stockholm, www.baltichorizon.com To receive Nasdaq announcements and news from Baltic Horizon Fund about its projects, plans and more, register on www.baltichorizon.com. You can also follow...

The general meeting of shareholders of Northern Horizon Capital AS, the management company of Baltic Horizon Fund, has approved the management company’s audited annual report of year 2024. The report, together with the independent auditors’ report is available on the Baltic Horizon Fund webpage. For additional information, please contact: Tarmo Karotam Baltic Horizon Fund manager E-mail tarmo.karotam@nh-cap.com www.baltichorizon.com The Fund is a registered contractual public closed-end real estate fund that is managed by Alternative Investment Fund Manager license holder Northern Horizon Capital AS.  Distribution: GlobeNewswire, Nasdaq Tallinn, Nasdaq Stockholm, www.baltichorizon.com To receive Nasdaq announcements and news from Baltic Horizon Fund about its projects, plans and more, register on www.baltichorizon.com. You can also follow...

WUXI, China, April 24, 2025 (GLOBE NEWSWIRE) — LOBO, a fast-growing electric mobility manufacturer, is pleased to announce its intent to initiate a strategic cooperation in Indonesia with Green Gold Asia to launch a new line of innovative electric bike and tricycle. This move is a key milestone in LOBO’s mission to expand globally and deliver accessible, green mobility to communities around the world. Indonesia is one of the most promising markets for electric mobility, driven by rapid urbanization, a growing middle class, and strong national commitments to sustainable development. With a population of over 270 million and increasing demand for environmentally friendly transportation, Indonesia’s EV market is projected to surpass $5 billion USD by 2030, with two- and three-wheel electric vehicles expected to lead adoption. In this...

CAMPBELL, Calif., April 24, 2025 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced it will release its financial results for the first quarter ended March 31, 2025, after market close on Tuesday, May 13, 2025. Management will host a conference call on Tuesday, May 13, 2025, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing:  United States/Canada Toll Free:   +1-800-717-1738  International Toll:   +1-646-307-1865       Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A live webcast will be available in the Investor Relations section of Arteris’ website at: https://ir.arteris.com/events-and-presentations. A replay of the...